Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Sites will identify patients who meet the entry criteria during the conduct of their normal practice. Patients meeting these criteria will be offered participation in the study after reading and completing an informed consent document.
Age
45–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Male aged ≥45 years;
Experienced abrupt visual change in only 1 eye
You may not be if
Pain determined by an ophthalmologist to be consistent with an inflammatory/arteritic process or optic neuritis;
History of NAION or optic neuritis.
Participation in other studies within 60 days prior to entry in the study.
Clareo Health | A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
